Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 129   

Articles published

ABT 42.86 -0.03 (-0.07%)
price chart
Abbott Labs to Sell Generic Drug Assets to Mylan
Abbott will receive about a 21% stake, or 105 million shares, of a newly formed entity that will combine Mylan's existing business and Abbott's generic pharmaceuticals business in developed markets not including the U.S. The new entity will be ...
Mylan to Buy Abbott's Generic Drug Business Outside US for $5.3 Billion  New York Times
Mylan to buy Abbott generics, cut taxes, in $5.3 billion deal  Reuters
Related articles »  
Why Growth Is Coming to Abbott Laboratories Stock
Abbott Laboratories (NYSE: ABT ) markets everything from Similac baby formula to cataract surgery equipment and its restructuring itself in order to spark revenue growth.
Abbott Laboratories' (ABT) CEO, Miles White on Q2 2014 Results ...  Seeking Alpha
Abbott Streamlines Generic Drug Business With Sale Of Developed Market ...  Forbes
Related articles »  
Ex-Dividend Reminder: AbbVie, Abbott Laboratories and Rouse Properties
Looking at the universe of stocks we cover at Dividend Channel, on 7/11/14, AbbVie AbbVie Inc. (NYSE: ABBV), Abbott Laboratories Abbott Laboratories (NYSE: ABT), and Rouse Properties Rouse Properties, Inc. (NYSE: RSE) will all trade ex-dividend for ...
Related articles »  
Will These EPS Estimate Cuts Hurt Abbott Laboratories (ABT) Stock Today?
"We rate ABBOTT LABORATORIES (ABT) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance ...
Abbott Laboratories Receives Consensus Recommendation of "Hold" from ...
Abbott Laboratories logo Shares of Abbott Laboratories (NYSE:ABT) have received an average rating of �Hold� from the fifteen ratings firms that are covering the stock, American Banking News reports.
Abbott Laboratories Now #70 Largest Company, Surpassing Colgate-Palmolive
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock.
Related articles »  
Is Abbott Laboratories Better Than Johnson & Johnson For Your Dividend ...
Find out if ABT is a better buy today than JNJ for dividend growth investors. Both Abbott Laboratories and Johnson & Johnson were founded in the 1800s.
Earnings Preview: Abbott Laboratories and Johnson & Johnson  Motley Fool
Why This Institutional Favorite Tops My List Of Stocks  Investing.com
Related articles »  
Mylan Chasing Abbott's Multi-Billion Dollar Off-Patent Drugs Portfolio
Mylan Inc. (MYL) is reportedly in serious talks with Abbott Laboratories (ABT) to acquire its well-established products portfolio.
Mylan near multibillion-dollar deal for Abbott drug assets - sources  Reuters UK
Related articles »  
Market Update: Abbott Laboratories (NYSE:ABT) � Abbott Introduces New ...
Abbott Laboratories (NYSE:ABT) [PR Newswire] - Abbott (ABT), the makers of Similac� and experts in infant nutrition for nearly 90 years, studied the diets of more than 80 lactating women to assess how their nutritional intake compared to dietary ...
Related articles »  
Why Abbott Labs' Tipp City plant is a bigger deal than you probably realize
After more than two years of fanfare, the Abbott Laboratories plant in Tipp City is officially open for business. Local officials, along with top brass at the company's Abbott Nutrition division and Lt.
New Abbott Laboratories Plant Opens in Tipp City  WKEF ABC 22
Related articles »